Crossref journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
Bibliography

Davies, J. E., Sarkar, S., & Rubinsztein, D. C. (2008). Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. Human Molecular Genetics, 17(8), 1097–1108.

Authors 3
  1. Janet E. Davies (first)
  2. Sovan Sarkar (additional)
  3. David C. Rubinsztein (additional)
References 42 Referenced 38
  1. 10.1038/ng0298-164 / Nat. Genet / Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy by Brais (1998)
  2. 10.1016/j.bbadis.2006.10.003 / Biochim. Biophys. Acta / Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies by Abu-Baker (2007)
  3. 10.1016/j.biocel.2006.01.016 / Int. J. Biochem. Cell Biol / Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder by Davies (2006)
  4. 10.1093/oxfordjournals.hmg.a018924 / Hum. Mol. Genet / Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA by Calado (2000)
  5. 10.1016/S0960-8966(97)00085-0 / Neuromuscul. Disord / Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy by Tome (1997)
  6. 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0 / Muscle Nerve / Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy by Uyama (2000)
  7. 10.1038/nm1242 / Nat. Med / Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice by Davies (2005)
  8. 10.1074/jbc.M109633200 / J. Biol. Chem / Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy by Bao (2002)
  9. 10.1136/jmg.2003.014548 / J. Med. Genet / Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy by Bao (2004)
  10. 10.1093/hmg/ddi331 / Hum. Mol. Genet / Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway by Berger (2005)
  11. 10.1038/sj.emboj.7601117 / Embo J / A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1 by Chartier (2006)
  12. 10.1016/j.bbaexp.2004.03.008 / Biochim. Biophys. Acta / Structure and function of poly(A) binding proteins by Kuhn (2004)
  13. 10.1017/S1355838200991908 / RNA / Deciphering the cellular pathway for transport of poly(A)-binding protein II by Calado (2000)
  14. 10.1016/j.devcel.2005.09.002 / Dev. Cell / An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila by Benoit (2005)
  15. 10.1093/hmg/10.21.2341 / Hum. Mol. Genet / Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death by Fan (2001)
  16. 10.1038/sj.embor.7400795 / EMBO Rep / Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family by Eckelman (2006)
  17. 10.1016/S0278-5846(03)00017-4 / Prog. Neuropsychopharmacol. Biol. Psychiatry / Natural cellular inhibitors of caspases by LeBlanc (2003)
  18. 10.1523/JNEUROSCI.20-24-09126.2000 / J. Neurosci / Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease by Eberhardt (2000)
  19. 10.1038/sj.gt.3302683 / Gene Ther / XIAP-mediated neuroprotection in retinal ischemia by Renwick (2006)
  20. 10.1038/sj.gt.3302927 / Gene Ther / X-chromosome linked inhibitor of apoptosis protein inhibits muscle proteolysis in insulin-deficient mice by Wang (2007)
  21. 10.1158/1535-7163.MCT-06-0426 / Mol. Cancer Ther / Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites by Lee (2006)
  22. 10.1084/jem.188.1.211 / J. Exp. Med / Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis by Stehlik (1998)
  23. 10.1038/11109 / Nat. Cell. Biol / A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection by Holcik (1999)
  24. 10.1126/science.288.5467.874 / Science / Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli by Yang (2000)
  25. 10.1006/geno.1997.4742 / Genomics / Genomic organization and primary characterization of miap-3: the murine homologue of human X-linked IAP by Farahani (1997)
  26. 10.1006/geno.2001.6635 / Genomics / Genomic organization of the X-linked inhibitor of apoptosis and identification of a novel testis-specific transcript by Lagace (2001)
  27. 10.1261/rna.5225204 / RNA / Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures by Van Eden (2004)
  28. 10.1016/S0378-1119(03)00774-1 / Gene / Alternative ways to think about mRNA sequences and proteins that appear to promote internal initiation of translation by Kozak (2003)
  29. 10.1128/MCB.16.11.6573 / Mol. Cell Biol / Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc by Polunovsky (1996)
  30. 10.1128/MCB.22.8.2853-2861.2002 / Mol. Cell Biol / Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency by Li (2002)
  31. 10.1053/j.gastro.2004.09.002 / Gastroenterology / Translational regulation of XIAP expression and cell survival during hypoxia in human cholangiocarcinoma by Marienfeld (2004)
  32. 10.1158/0008-5472.CAN-05-2447 / Cancer Res / Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis by Yan (2006)
  33. 10.1016/j.molmed.2006.04.003 / Trends Mol. Med / The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy by Miller (2006)
  34. 10.1016/S0960-8966(02)00030-5 / Neuromuscul. Disord / Apoptosis and muscle fibre loss in neuromuscular disorders by Tews (2002)
  35. 10.1038/ng1270 / Nat. Genet / Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency by Irwin (2003)
  36. 10.1242/jcs.00806 / J. Cell Sci / A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes by Smythe (2003)
  37. 10.1242/jcs.108.6.2197 / J. Cell Sci / Apoptosis precedes necrosis of dystrophin-deficient muscle by Tidball (1995)
  38. {'key': 'key\n\t\t\t\t20170522143040_DDM382C38', 'first-page': '1005', 'article-title': 'Apoptotic myonuclei in human Duchenne muscular dystrophy', 'volume': '78', 'author': 'Sandri', 'year': '1998', 'journal-title': 'Lab. Invest'} / Lab. Invest / Apoptotic myonuclei in human Duchenne muscular dystrophy by Sandri (1998)
  39. 10.1093/hmg/ddi095 / Hum. Mol. Genet / Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice by Dominov (2005)
  40. 10.1172/JCI22928 / J. Clin. Invest / Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy by Girgenrath (2004)
  41. 10.1093/hmg/ddh017 / Hum. Mol. Genet / Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy by Hino (2004)
  42. 10.1083/jcb.139.5.1281 / J. Cell Biol / Movement of Bax from the cytosol to mitochondria during apoptosis by Wolter (1997)
Dates
Type When
Created 17 years, 7 months ago (Jan. 4, 2008, 8:25 p.m.)
Deposited 3 years, 11 months ago (Aug. 31, 2021, 10:11 p.m.)
Indexed 1 month ago (July 30, 2025, 10:52 a.m.)
Issued 17 years, 7 months ago (Jan. 4, 2008)
Published 17 years, 7 months ago (Jan. 4, 2008)
Published Online 17 years, 7 months ago (Jan. 4, 2008)
Published Print 17 years, 4 months ago (April 15, 2008)
Funders 0

None

@article{Davies_2008, title={Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation}, volume={17}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddm382}, DOI={10.1093/hmg/ddm382}, number={8}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Davies, Janet E. and Sarkar, Sovan and Rubinsztein, David C.}, year={2008}, month=jan, pages={1097–1108} }